When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MTFB - Motif Bio receives FDA minutes for iclaprim; shares down 35% premarket
Motif Bio plc
Motif Bio (NASDAQ:MTFB) has received the official minutes of the Type A meeting held with FDA on May 3, to discuss the points raised in the Complete Response Letter (CRL) related to the NDA for iclaprim, for the treatment of acute bacterial skin and skin structure infections.
More news on: Motif Bio plc, Healthcare stocks news, Stocks on the move,